Resection of nonalcoholic steatohepatitis-associated hepatocellular carcinoma: A western experience

International Journal of Surgical Oncology

Volumn 2012, Issue , 2012, Pages

  Shrager, Brian ^a   Jibara, Ghalib A ^a   Tabrizian, Parissa ^a   Roayaie, Sasan ^a   Ward, Stephen C ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84867828235     PISSN: 20901402     EISSN: 20901410     Source Type: Journal    
DOI: 10.1155/2012/915128     Document Type: Article

References (38)

1. Ertle J., Dechêne A., Sowa J. P., Penndorf V., Herzer K., Kaiser G., Schlaak J. F., Gerken G., Syn W. K., Canbay A., Non-alcoholic fatty liver disease progresses to hepatocellular carcinoma in the absence of apparent cirrhosis. International Journal of Cancer 2011 128 10 2436 2443 2-s2.0-79953185045 10.1002/ijc.25797
2. Marchesini G., Brizi M., Blanchi G., Tomassetti S., Bugianesi E., Lenzi M., McCullough A. J., Natale S., Forlani G., Melchionda N., Nonalcoholic fatty liver disease: a feature of the metabolic syndrome. Diabetes 2001 50 8 1844 1850 2-s2.0-0035431018
3. Bugianesi E., Leone N., Vanni E., Marchesini G., Brunello F., Carucci P., Musso A., De Paolis P., Capussotti L., Salizzoni M., Rizzetto M., Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinoma. Gastroenterology 2002 123 1 134 140 2-s2.0-0036302288 10.1053/gast.2002.34168
4. Marchesini G., Bugianesi E., Forlani G., Cerrelli F., Lenzi M., Manini R., Natale S., Vanni E., Villanova N., Melchionda N., Rizzetto M., Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003 37 4 917 923 2-s2.0-0037382786 10.1053/jhep.2003.50161
5. Brunt E. M., Janney C. G., Di Bisceglie A. M., Neuschwander-Tetri B. A., Bacon B. R., Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. American Journal of Gastroenterology 1999 94 9 2467 2474 2-s2.0-0033200054 10.1111/j.1572-0241.1999.01377.x
6. Caldwell S. H., Crespo D. M., Kang H. S., Al-Osaimi A. M. S., Obesity and hepatocellular carcinoma. Gastroenterology 2004 127 S97 S103 2-s2.0-7044235603 10.1053/j.gastro.2004.09.021
7. Ascha M. S., Hanouneh I. A., Lopez R., Tamimi T. A. R., Feldstein A. F., Zein N. N., The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010 51 6 1972 1978 2-s2.0-77952730428 10.1002/hep.23527
8. Calle E. E., Rodriguez C., Walker-Thurmond K., Thun M. J., Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults. The New England Journal of Medicine 2003 348 17 1625 1638 2-s2.0-0037464510 10.1056/NEJMoa021423
9. Adami H. O., Chow W. H., Nyrén O., Berne C., Linet M. S., Ekbom A., Wolk A., McLaughlin J. K., Fraumeni J. F., Excess risk of primary liver cancer in patients with diabetes mellitus. Journal of the National Cancer Institute 1996 88 20 1472 1477 2-s2.0-0029821203 10.1093/jnci/88.20.1472
10. Wideroff L., Gridley G., Mellemkjaer L., Chow W. H., Linet M., Keehn S., Borch-Johnsen K., Olsen J. H., Cancer incidence in a population-based cohort of patients hospitalized with diabetes mellitus in denmark. Journal of the National Cancer Institute 1997 89 18 1360 1365 2-s2.0-0030774675
11. El-Serag H. B., Tran T., Everhart J. E., Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. Gastroenterology 2004 126 2 460 468 2-s2.0-0842321807 10.1053/j.gastro.2003.10.065
12. Shimada M., Hashimoto E., Taniai M., Hasegawa K., Okuda H., Hayashi N., Takasaki K., Ludwig J., Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis. Journal of Hepatology 2002 37 1 154 160 2-s2.0-0035991455 10.1016/S0168-8278(02)00099-5
13. Chagas A. L., Kikuchi L. O. O., Oliveira C. P. M. S., Vezozzo D. C. P., Mello E. S., Oliveira A. C., Cella L. C., Herman P., Bachella T., Caldwell S. H., Alves V. A. F., Carrilho F. J., Does hepatocellular carcinoma in non-alcoholic steatohepatitis exist in cirrhotic and non-cirrhotic patients? Brazilian Journal of Medical and Biological Research 2009 42 10 958 962 2-s2.0-71049127867 10.1590/S0100-879X2009005000019
14. Hashimoto E., Yatsuji S., Tobari M., Taniai M., Torii N., Tokushige K., Shiratori K., Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Journal of Gastroenterology 2009 44 19, supplement 89 95 2-s2.0-58849090967 10.1007/s00535-008-2262-x
15. Hashizume H., Sato K., Takagi H., Hirokawa T., Kojima A., Sohara N., Kakizaki S., Mochida Y., Shimura T., Sunose Y., Ohwada S., Mori M., Primary liver cancers with nonalcoholic steatohepatitis. European Journal of Gastroenterology and Hepatology 2007 19 10 827 834 2-s2.0-34548674927 10.1097/MEG.0b013e3282748ef2
16. Kawada N., Imanaka K., Kawaguchi T., Tamai C., Ishihara R., Matsunaga T., Gotoh K., Yamada T., Tomita Y., Hepatocellular carcinoma arising from non-cirrhotic nonalcoholic steatohepatitis. Journal of Gastroenterology 2009 44 12 1190 1194 2-s2.0-73449130477 10.1007/s00535-009-0112-0
17. Malik S. M., Gupte P. A., de Vera M. E., Ahmad J., Liver transplantation in patients with nonalcoholic steatohepatitis-related hepatocellular carcinoma. Clinical Gastroenterology and Hepatology 2009 7 7 800 806 2-s2.0-67649313330 10.1016/j.cgh.2009.02.025
18. Tokushige K., Hashimoto E., Yatsuji S., Tobari M., Taniai M., Torii N., Shiratori K., Prospective study of hepatocellular carcinoma in nonalcoholic steatohepatitis in comparison with hepatocellular carcinoma caused by chronic hepatitis C. Journal of Gastroenterology 2010 45 9 960 967 2-s2.0-77956927733 10.1007/s00535-010-0237-1
19. Takuma Y., Nouso K., Nonalcoholic steatohepatitis-associated hepatocellular carcinoma: our case series and literature review. World Journal of Gastroenterology 2010 16 12 1436 1441 2-s2.0-77950803622 10.3748/wjg.v16.i12. 1436
20. World Health Organization, Definition, Diagnosis and Classification of Diabetes Mellitus and Its Complications 1999 World Health Organization, Department of Noncommunicable Disease Surveillance
21. Cleeman J. I., Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Journal of the American Medical Association 2001 285 19 2486 2497 2-s2.0-0035897696
22. Sattar N., Gaw A., Scherbakova O., Ford I., O'Reilly D. S. J., Haffner S. M., Isles C., Macfarlane P. W., Packard C. J., Cobbe S. M., Shepherd J., Metabolic syndrome with and without C-reactive protein as a predictor of coronary heart disease and diabetes in the West of Scotland Coronary Prevention Study. Circulation 2003 108 4 414 419 2-s2.0-0042665536 10.1161/01.CIR. 0000080897.52664.94
23. Bruix J., Sherman M., Llovet J. M., Beaugrand M., Lencioni R., Burroughs A. K., Christensen E., Pagliaro L., Colombo M., Rodés J., Clinical management of hepatocellular carcinoma. Conclusions of the barcelona-2000 EASL conference. Journal of Hepatology 2001 35 3 421 430 2-s2.0-0034856294 10.1016/S0168-8278(01)00130-1
24. Edmonson H. A., Steiner P. E., Primary carcinoma of the liver: a study of 100 cases among 48,900. Cancer 1954 7 3 462 503 2-s2.0-78651053628
25. Giannini E. G., Marabotto E., Savarino V., Trevisani F., di Nolfo M. A., Poggio P. D., Benvegnù L., Farinati F., Zoli M., Borzio F., Caturelli E., Chiaramonte M., Hepatocellular carcinoma in patients with cryptogenic cirrhosis. Clinical Gastroenterology and Hepatology 2009 7 5 580 585 2-s2.0-67349157155 10.1016/j.cgh.2009.01.001
26. Starley B. Q., Calcagno C. J., Harrison S. A., Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection. Hepatology 2010 51 5 1820 1832 2-s2.0-77951456114 10.1002/hep.23594
27. Regimbeau J. M., Columbat M., Mognol P., Durand F., Abdalla E., Degott C., Degos F., Farges O., Belghiti J., Obesity and diabetes as a risk factor for hepatocellular carcinoma. Liver Transplantation 2004 10 2 S69 S73 2-s2.0-1242352395
28. Paradis V., Zalisnski S., Chelbi E., Guedj N., Degos F., Vilgrain V., Bedossa P., Belghiti J., Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liverfibrosis: a pathological analysis. Hepatology 2009 49 3 851 859 2-s2.0-63349085247 10.1002/hep.22734
29. Komorizono Y., Shibatou T., Sako K., Cryptogenic hepatocellular carcinoma and nonalcoholic steatohepatitis: a review of ten Japanese cases [AASLD abstract 1221]. Hepatology 2006 44 4, supplement 1 644A 645A
30. Guzman G., Brunt E. M., Petrovic L. M., Chejfec G., Layden T. J., Cotler S. J., Does nonalcoholic fatty liver disease predispose patients to hepatocellular carcinoma in the absence of cirrhosis? Archives of Pathology and Laboratory Medicine 2008 132 11 1761 1766 2-s2.0-55549106451 10.10432F1543-2165-132.11.1761
31. Weyer C., Hanson R. L., Tataranni P. A., Bogardus C., Pratley R. E., A high fasting plasma insulin concentration predicts type 2 diabetes independent of insulin resistance: evidence for a pathogenic role of relative hyperinsulinemia. Diabetes 2000 49 12 2094 2101 2-s2.0-0033656672
32. Saito K., Inoue S., Saito T., Kiso S., Ito N., Tamura S., Watanabe H., Takeda H., Misawa H., Togashi H., Matsuzawa Y., Kawata S., Augmentation effect of postprandial hyperinsulinaemia on growth of human hepatocellular carcinoma. Gut 2002 51 1 100 104 2-s2.0-0036296994 10.1136/gut.51.1.100
33. Price J. A., Kovach S. J., Johnson T., Koniaris L. G., Cahill P. A., Sitzmann J. V., McKillop I. H., Insulin-like growth factor I is a comitogen for hepatocyte growth factor in a rat model of hepatocellular carcinoma. Hepatology 2002 36 5 1089 1097 2-s2.0-0036828754 10.1053/jhep.2002.36158
34. Marnett L. J., Oxyradicals and DNA damage. Carcinogenesis 2000 21 3 361 370 2-s2.0-0034011261
35. Hu W., Feng Z., Eveleigh J., Iyer G., Pan J., Amin S., Chung F. L., Tang M. S., The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma. Carcinogenesis 2002 23 11 1781 1789 2-s2.0-0036850924
36. Yang S., Lin H. Z., Hwang J., Chacko V. P., Diehl A. M., Hepatic hyperplasia in noncirrhotic fatty livers: is obesity-related hepatic steatosis a premalignant condition? Cancer Research 2001 61 13 5016 5023 2-s2.0-0035392939
37. Roskams T., Yang S. Q., Koteish A., Durnez A., DeVos R., Huang X., Achten R., Verslype C., Diehl A. M., Oxidative stress and oval cell accumulation in mice and humans with alcoholic and nonalcoholic fatty liver disease. American Journal of Pathology 2003 163 4 1301 1311 2-s2.0-0042033294
38. Sánchez A., Factor V. M., Schroeder I. S., Nagy P., Thorgeirsson S. S., Activation of NF- κ B and STAT3 in rat oval cells during 2-acetylaminofluorene/partial hepatectomy-induced liver regeneration. Hepatology 2004 39 2 376 385 2-s2.0-1242291930 10.1002/hep.20040